<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39385791</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-861X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in nutrition</Title><ISOAbbreviation>Front Nutr</ISOAbbreviation></Journal><ArticleTitle>The impact of supplementing vitamin D through different methods on the prognosis of COVID-19 patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1441847</StartPage><MedlinePgn>1441847</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1441847</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnut.2024.1441847</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To analyze the impact of different methods of Vitamin D administration on the prognosis of COVID-19 patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A comprehensive literature search was conducted across four databases: PubMed, Embase, Web of Science, and Cochrane, up to January 5, 2024. Eligible studies included randomized controlled trials and cohort studies that compared Vitamin D supplementation with control groups in COVID-19 patients. Outcomes of interest were mortality rate, ICU (Intensive Care Unit) admission rate, length of hospital stay, and endotracheal intubation rate. Subgroup analyses were performed based on the dosing regimen (single-dose vs. continuous-dose), total Vitamin D intake within 14 days (≥100,000 IU vs. &lt;100,000 IU), and baseline serum Vitamin D levels (deficient group: 25OHD &lt; 30 ng/mL vs. non-restricted group). A random-effects model was employed for meta-analysis to account for heterogeneity among studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 21 studies involving 4,553 participants were included. In terms of mortality, Vitamin D supplementation significantly reduced the mortality rate (RR = 0.72, 95% CI: 0.54-0.94, <i>I</i> <sup>2</sup> = 54%, <i>p</i> = 0.02), with continuous dosing being more effective (RR = 0.53, 95% CI: 0.34-0.83, <i>I</i> <sup>2</sup> = 55%, <i>p</i> = 0.006) compared to single-dose (RR = 0.88, 95% CI: 0.69-1.12, <i>I</i> <sup>2</sup> = 21%, <i>p</i> = 0.3), and lower total doses (&lt;100,000 IU) showing greater benefit (RR = 0.30, 95% CI: 0.21-0.44, <i>I</i> <sup>2</sup> = 0%, <i>p</i> &lt; 0.0001). Mortality was significantly reduced in the Vitamin D-deficient group (25OHD &lt; 30 ng/mL) (RR = 0.73, 95% CI: 0.59-0.89, <i>I</i> <sup>2</sup> = 0%, <i>p</i> = 0.002) but not in the non-restricted group. Regarding ICU admission, supplementation reduced ICU admission rates (RR = 0.58, 95% CI: 0.38-0.88, <i>I</i> <sup>2</sup> = 74%, <i>p</i> = 0.01), with continuous dosing (RR = 0.44, 95% CI: 0.22-0.90, <i>I</i> <sup>2</sup> = 74%, <i>p</i> = 0.02) being more effective than single-dose (RR = 0.79, 95% CI: 0.61-1.03, <i>I</i> <sup>2</sup> = 22%, <i>p</i> = 0.08), and lower doses (&lt;100,000 IU) providing more significant reduction (RR = 0.31, 95% CI: 0.21-0.47, <i>I</i> <sup>2</sup> = 0%, <i>p</i> = 0.001). ICU admission rates were significantly reduced in the Vitamin D-deficient group (RR = 0.63, 95% CI: 0.42-0.93, <i>I</i> <sup>2</sup> = 0%, <i>p</i> = 0.02) but not in the non-restricted group (RR = 0.59, 95% CI: 0.32-1.11, <i>I</i> <sup>2</sup> = 86%, <i>p</i> = 0.1). For length of hospital stay, no significant differences were observed between Vitamin D and control groups (MD = -1, 95% CI: -2.16 to 0.16, <i>p</i> = 0.13), and subgroup analyses by dosing regimen, total dose, and baseline Vitamin D levels also showed no significant differences. Similarly, for endotracheal intubation, there was no significant difference in intubation rates between groups (RR = 0.78, 95% CI: 0.56-1.08, <i>p</i> = 0.13), and subgroup analyses confirmed no significant effect of different dosing strategies or baseline Vitamin D status on intubation rates.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Vitamin D supplementation improves clinical outcomes in COVID-19 patients by reducing mortality and ICU admission rates, particularly when administered continuously with a total dose of less than 100,000 IU over 14 days, and among those with baseline Vitamin D deficiency (25OHD &lt; 30 ng/mL). However, there were no significant effects on the length of hospital stay or endotracheal intubation rates, regardless of the dosing regimen or baseline Vitamin D levels. These findings emphasize the importance of considering both the total dose over 14 days and baseline Vitamin D status to optimize therapeutic benefits.</AbstractText><CopyrightInformation>Copyright © 2024 Zhang, Wu, Dong, Shang, Li, Zhang, Guo and Mei.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiangqun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Junyuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Hongmeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yixuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Guo</LastName><ForeName>Shubin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mei</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nutr</MedlineTA><NlmUniqueID>101642264</NlmUniqueID><ISSNLinking>2296-861X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">administration methods</Keyword><Keyword MajorTopicYN="N">baseline vitamin D</Keyword><Keyword MajorTopicYN="N">dosage</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39385791</ArticleId><ArticleId IdType="pmc">PMC11462671</ArticleId><ArticleId IdType="doi">10.3389/fnut.2024.1441847</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. (2017) 27:e1909. doi: 10.1002/rmv.1909</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1909</ArticleId><ArticleId IdType="pubmed">27714929</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaghari-Tabari M, Mohammadzadeh I, Qujeq D, Majidinia M, Alemi F, Younesi S, et al. . Vitamin D in respiratory viral infections: a key immune modulator? Crit Rev Food Sci Nutr. (2023) 63:2231–46. doi: 10.1080/10408398.2021.1972407, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2021.1972407</ArticleId><ArticleId IdType="pubmed">34470511</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri A, Infante M, Ricordi C. Editorial - vitamin D status: a key modulator of innate immunity and natural defense from acute viral respiratory infections. Eur Rev Med Pharmacol Sci. (2020) 24:4048–52. doi: 10.26355/eurrev_202004_20876, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202004_20876</ArticleId><ArticleId IdType="pubmed">32329882</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraf R, Jensen BP, Camargo CA, Jr, Morton SMB, Jing M, Sies CW, et al. . Vitamin D status at birth and acute respiratory infection hospitalisation during infancy. Paediatr Perinat Epidemiol. (2021) 35:540–8. doi: 10.1111/ppe.12755, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ppe.12755</ArticleId><ArticleId IdType="pubmed">33792941</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry DJ, Hesketh K, Power C, Hyppönen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr. (2011) 106:1433–40. doi: 10.1017/S0007114511001991, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114511001991</ArticleId><ArticleId IdType="pubmed">21736791</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe DA, Camargo CA, Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, et al. . Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. (2021) 9:276–92. doi: 10.1016/S2213-8587(21)00051-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00051-6</ArticleId><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlieg-Boerstra B, de Jong N, Meyer R, Agostoni C, De Cosmi V, Grimshaw K, et al. . Nutrient supplementation for prevention of viral respiratory tract infections in healthy subjects: a systematic review and meta-analysis. Allergy. (2022) 77:1373–88. doi: 10.1111/all.15136, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15136</ArticleId><ArticleId IdType="pubmed">34626488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Fang F, Tang J, Jia L, Feng Y, Xu P, et al. . Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. (2019) 366:l4673. doi: 10.1136/bmj.l4673</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4673</ArticleId><ArticleId IdType="pmc">PMC6689821</ArticleId><ArticleId IdType="pubmed">31405892</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler G, Corvaisier M, Gautier J, Dubée V, Legrand E, Sacco G, et al. . Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study. Nutrients. (2020) 12:3377. doi: 10.3390/nu12113377, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12113377</ArticleId><ArticleId IdType="pmc">PMC7693938</ArticleId><ArticleId IdType="pubmed">33147894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Eltriki M, Hopefl R, Wright JM, Deb S. Association between vitamin D status and risk of developing severe COVID-19 infection: a Meta-analysis of observational studies. J Am Nutr Assoc. (2022) 41:679–89. doi: 10.1080/07315724.2021.1951891, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2021.1951891</ArticleId><ArticleId IdType="pmc">PMC8425440</ArticleId><ArticleId IdType="pubmed">34464543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dror AA, Morozov N, Daoud A, Namir Y, Yakir O, Shachar Y, et al. . Pre-infection 25-hydroxyVitamin D3 levels and association with severity of COVID-19 illness. PLoS One. (2022) 17:e0263069. doi: 10.1371/journal.pone.0263069, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263069</ArticleId><ArticleId IdType="pmc">PMC8812897</ArticleId><ArticleId IdType="pubmed">35113901</ArticleId></ArticleIdList></Reference><Reference><Citation>Oscanoa TJ, Amado J, Vidal X, Laird E, Ghashut RA, Romero-Ortuno R. The relationship between the severity and mortality of SARS-CoV-2 infection and 25-hydroxyVitamin D concentration - a metaanalysis. Adv Respir Med. (2021) 89:145–57. doi: 10.5603/ARM.a2021.0037, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/ARM.a2021.0037</ArticleId><ArticleId IdType="pubmed">33966262</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelidi AM, Belanger MJ, Lorinsky MK, Karamanis D, Chamorro-Pareja N, Ognibene J, et al. . Vitamin D status is associated with in-hospital mortality and mechanical ventilation: a cohort of COVID-19 hospitalized patients. Mayo Clin Proc. (2021) 96:875–86. doi: 10.1016/j.mayocp.2021.01.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.01.001</ArticleId><ArticleId IdType="pmc">PMC7834253</ArticleId><ArticleId IdType="pubmed">33714594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabico S, Enani MA, Sheshah E, Aljohani NJ, Aldisi DA, Alotaibi NH, et al. . Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate Covid-19: a randomized clinical trial. Nutrients. (2021) 13:2170. doi: 10.3390/nu13072170, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072170</ArticleId><ArticleId IdType="pmc">PMC8308273</ArticleId><ArticleId IdType="pubmed">34202578</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi-Newton S, Kong MF, et al. . High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-Centre observational study. Nutrients. (2020) 12:3799. doi: 10.3390/nu12123799, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12123799</ArticleId><ArticleId IdType="pmc">PMC7763301</ArticleId><ArticleId IdType="pubmed">33322317</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R, Martin-Escalante MD, Cortes-Rodriguez B, Zambrana-Garcia JL, et al. . Calcifediol treatment and hospital mortality due to COVID-19: a cohort study. Nutrients. (2021) 13:1760. doi: 10.3390/nu13061760, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13061760</ArticleId><ArticleId IdType="pmc">PMC8224356</ArticleId><ArticleId IdType="pubmed">34064175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonen MS, Alaylioglu M, Durcan E, Ozdemir Y, Sahin S, Konukoglu D, et al. . Rapid and effective vitamin D supplementation may present better clinical outcomes in COVID-19 (SARS-CoV-2) patients by altering serum INOS1, IL1B, IFNg, cathelicidin-LL37, and ICAM1. Nutrients. (2021) 13:12. doi: 10.3390/nu13114047</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13114047</ArticleId><ArticleId IdType="pmc">PMC8618389</ArticleId><ArticleId IdType="pubmed">34836309</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervero M, Lopez-Wolf D, Casado G, Novella-Mena M, Ryan-Murua P, Taboada-Martinez ML, et al. . Beneficial effect of short-term supplementation of high dose of vitamin D(3) in hospitalized patients with COVID-19: a multicenter, single-blinded, prospective randomized pilot clinical trial. Front Pharmacol. (2022) 13:863587. doi: 10.3389/fphar.2022.863587, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.863587</ArticleId><ArticleId IdType="pmc">PMC9289223</ArticleId><ArticleId IdType="pubmed">35860019</ArticleId></ArticleIdList></Reference><Reference><Citation>De Niet S, Tremege M, Coffiner M, Rousseau AF, Calmes D, Frix AN, et al. . Positive effects of vitamin D supplementation in patients hospitalized for COVID-19: a randomized, double-blind, placebo-controlled trial. Nutrients. (2022) 14:3048. doi: 10.3390/nu14153048</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14153048</ArticleId><ArticleId IdType="pmc">PMC9330587</ArticleId><ArticleId IdType="pubmed">35893907</ArticleId></ArticleIdList></Reference><Reference><Citation>Guven M, Gultekin H. The effect of high-dose parenteral vitamin D(3) on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: an observational cohort study. Eur J Clin Nutr. (2021) 75:1383–8. doi: 10.1038/s41430-021-00984-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-021-00984-5</ArticleId><ArticleId IdType="pmc">PMC8299443</ArticleId><ArticleId IdType="pubmed">34302132</ArticleId></ArticleIdList></Reference><Reference><Citation>Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, Asadi A, Zarei A, Zendehdel A, et al. . Treatment with 25-HydroxyVitamin D(3) (Calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in hospitalized patients with COVID-19: a pilot multicenter, randomized, placebo-controlled, double-blinded clinical trial. Endocr Pract. (2021) 27:1242–51. doi: 10.1016/j.eprac.2021.09.016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.09.016</ArticleId><ArticleId IdType="pmc">PMC8511889</ArticleId><ArticleId IdType="pubmed">34653608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawat D, Roy A, Maitra S, Shankar V, Khanna P, Baidya DK. Vitamin D supplementation and COVID-19 treatment: a systematic review and meta-analysis. Diabetes Metab Syndr. (2021) 15:102189. doi: 10.1016/j.dsx.2021.102189, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102189</ArticleId><ArticleId IdType="pmc">PMC8236412</ArticleId><ArticleId IdType="pubmed">34217144</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannata-Andía JB, Díaz-Sottolano A, Fernández P, Palomo-Antequera C, Herrero-Puente P, Mouzo R, et al. . A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial. BMC Med. (2022) 20:83. doi: 10.1186/s12916-022-02290-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02290-8</ArticleId><ArticleId IdType="pmc">PMC8853840</ArticleId><ArticleId IdType="pubmed">35177066</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani J, Antonietti L, Tajer C, Ferder L, Inserra F, Sanchez Cunto M, et al. . High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: multicentre randomized controlled clinical trial. PLoS ONE. (2022) 17:e0267918. doi: 10.1371/journal.pone.0267918, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267918</ArticleId><ArticleId IdType="pmc">PMC9140264</ArticleId><ArticleId IdType="pubmed">35622854</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. doi: 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. (2018) 27:1785–805. doi: 10.1177/0962280216669183, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280216669183</ArticleId><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. (2014) 14:135. doi: 10.1186/1471-2288-14-135, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. (2011) 343:d5928. doi: 10.1136/bmj.d5928, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. (2019) 366:l4898. doi: 10.1136/bmj.l4898</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. . Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. (2019) 10:Ed000142. doi: 10.1002/14651858.ED000142</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.ED000142</ArticleId><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler C, Beaudenon M, Gautier J, Gonsard J, Boucher S, Chapelet G, et al. . High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): a multicenter, open-label, randomized controlled superiority trial. PLoS Med. (2022) 19:e1003999. doi: 10.1371/journal.pmed.1003999, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003999</ArticleId><ArticleId IdType="pmc">PMC9154122</ArticleId><ArticleId IdType="pubmed">35639792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bychinin MV, Klypa TV, Mandel IA, Yusubalieva GM, Baklaushev VP, Kolyshkina NA, et al. . Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU. Sci Rep. (2022) 12:18604. doi: 10.1038/s41598-022-22045-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-22045-y</ArticleId><ArticleId IdType="pmc">PMC9632570</ArticleId><ArticleId IdType="pubmed">36329227</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilokpattanamongkol P, Yan C, Jayanama K, Ngamjanyaporn P, Sungkanuparph S, Rotjanapan P. Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial. BMC Complement Med Ther. (2024) 24:97. doi: 10.1186/s12906-024-04393-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-024-04393-6</ArticleId><ArticleId IdType="pmc">PMC10880207</ArticleId><ArticleId IdType="pubmed">38383361</ArticleId></ArticleIdList></Reference><Reference><Citation>Domazet Bugarin J, Dosenovic S, Ilic D, Delic N, Saric I, Ugrina I, et al. . Vitamin D supplementation and clinical outcomes in severe COVID-19 patients-randomized controlled trial. Nutrients. (2023) 15:1234. doi: 10.3390/nu15051234, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15051234</ArticleId><ArticleId IdType="pmc">PMC10005311</ArticleId><ArticleId IdType="pubmed">36904232</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamir YM, Amir H, Lim S, Rana YP, Lopez CG, Feliciano NV, et al. . A randomized pilot study using calcitriol in hospitalized COVID-19 patients. Bone. (2022) 154:116175. doi: 10.1016/j.bone.2021.116175, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2021.116175</ArticleId><ArticleId IdType="pmc">PMC8425676</ArticleId><ArticleId IdType="pubmed">34508882</ArticleId></ArticleIdList></Reference><Reference><Citation>Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcala Diaz JF, Lopez Miranda J, Bouillon R, et al. . Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. (2020) 203:105751. doi: 10.1016/j.jsbmb.2020.105751, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2020.105751</ArticleId><ArticleId IdType="pmc">PMC7456194</ArticleId><ArticleId IdType="pubmed">32871238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes AL, Sales LP, Santos MD, Caparbo VF, Murai IH, Pereira RMR. Persistent or new symptoms 1 year after a single high dose of vitamin D(3) in patients with moderate to severe COVID-19. Front Nutr. (2022) 9:979667. doi: 10.3389/fnut.2022.979667, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.979667</ArticleId><ArticleId IdType="pmc">PMC9513442</ArticleId><ArticleId IdType="pubmed">36176639</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore V, De Vito A, Bagella P, Princic E, Mariani AA, Denti L, et al. . Effectiveness of vitamin D supplements among patients hospitalized for COVID-19: results from a monocentric matched-cohort study. Healthcare (Basel). (2022) 10:956. doi: 10.3390/healthcare10050956</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10050956</ArticleId><ArticleId IdType="pmc">PMC9141918</ArticleId><ArticleId IdType="pubmed">35628093</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai IH, Fernandes AL, Antonangelo L, Gualano B, Pereira RMR. Effect of a single high-dose vitamin D3 on the length of hospital stay of severely 25-HydroxyVitamin D-deficient patients with COVID-19. Clinics (São Paulo). (2021) 76:e3549. doi: 10.6061/clinics/2021/e3549, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2021/e3549</ArticleId><ArticleId IdType="pmc">PMC8595591</ArticleId><ArticleId IdType="pubmed">34852148</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogues X, Ovejero D, Pineda-Moncusí M, Bouillon R, Arenas D, Pascual J, et al. . Calcifediol treatment and COVID-19-related outcomes. J Clin Endocrinol Metab. (2021) 106:e4017–27. doi: 10.1210/clinem/dgab405, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab405</ArticleId><ArticleId IdType="pmc">PMC8344647</ArticleId><ArticleId IdType="pubmed">34097036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarhan N, Abou Warda AE, Sarhan RM, Boshra MS, Mostafa-Hedeab G, ALruwaili BF, et al. . Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate-to-severe COVID-19 patients: A randomized clinical trial. Medicina (Kaunas). (2022) 58:1358. doi: 10.3390/medicina58101358</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101358</ArticleId><ArticleId IdType="pmc">PMC9609310</ArticleId><ArticleId IdType="pubmed">36295519</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Rastogi A, Puri GD, Ganesh V, Naik NB, Kajal K, et al. . Therapeutic high-dose vitamin D for vitamin D-deficient severe COVID-19 disease: randomized, double-blind, placebo-controlled study (SHADE-S). J Public Health (Oxf). (2024) 46:256–66. doi: 10.1093/pubmed/fdae007, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdae007</ArticleId><ArticleId IdType="pubmed">38291897</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah K, Saxena D, Mavalankar D. Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis. QJM. (2021) 114:175–81. doi: 10.1093/qjmed/hcab009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab009</ArticleId><ArticleId IdType="pmc">PMC7928587</ArticleId><ArticleId IdType="pubmed">33486522</ArticleId></ArticleIdList></Reference><Reference><Citation>Beran A, Mhanna M, Srour O, Ayesh H, Stewart JM, Hjouj M, et al. . Clinical significance of micronutrient supplements in patients with coronavirus disease 2019: a comprehensive systematic review and meta-analysis. Clin Nutr ESPEN. (2022) 48:167–77. doi: 10.1016/j.clnesp.2021.12.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.12.033</ArticleId><ArticleId IdType="pmc">PMC8755558</ArticleId><ArticleId IdType="pubmed">35331487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kümmel LS, Krumbein H, Fragkou PC, Hünerbein BL, Reiter R, Papathanasiou KA, et al. . Vitamin D supplementation for the treatment of COVID-19: a systematic review and meta-analysis of randomized controlled trials. Front Immunol. (2022) 13:1023903. doi: 10.3389/fimmu.2022.1023903, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1023903</ArticleId><ArticleId IdType="pmc">PMC9659578</ArticleId><ArticleId IdType="pubmed">36389703</ArticleId></ArticleIdList></Reference><Reference><Citation>Szarpak L, Filipiak KJ, Gasecka A, Gawel W, Koziel D, Jaguszewski MJ, et al. . Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis. Cardiol J. (2022) 29:188–96. doi: 10.5603/CJ.a2021.0122, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2021.0122</ArticleId><ArticleId IdType="pmc">PMC9007480</ArticleId><ArticleId IdType="pubmed">34642923</ArticleId></ArticleIdList></Reference><Reference><Citation>Tentolouris N, Samakidou G, Eleftheriadou I, Tentolouris A, Jude EB. The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression. Diabetes Metab Res Rev. (2022) 38:e3517. doi: 10.1002/dmrr.3517, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3517</ArticleId><ArticleId IdType="pmc">PMC9015406</ArticleId><ArticleId IdType="pubmed">34965318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Mei K, Xie L, Yuan P, Ma J, Yu P, et al. . Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs. Nutr J. (2021) 20:89. doi: 10.1186/s12937-021-00744-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-021-00744-y</ArticleId><ArticleId IdType="pmc">PMC8557713</ArticleId><ArticleId IdType="pubmed">34719404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaazouee MS, Eleisawy M, Abdalalaziz AM, Elhady MM, Ali OA, Abdelbari TM, et al. . Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials. Naunyn Schmiedeberg's Arch Pharmacol. (2023) 396:607–20. doi: 10.1007/s00210-022-02360-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-022-02360-x</ArticleId><ArticleId IdType="pmc">PMC9743115</ArticleId><ArticleId IdType="pubmed">36508011</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartini M, Del Puente F, Oliva M, Carbone A, Bobbio N, Schinca E, et al. . Preventive vitamin D supplementation and risk for COVID-19 infection: a systematic review and Meta-analysis. Nutrients. (2024) 16:679. doi: 10.3390/nu16050679, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16050679</ArticleId><ArticleId IdType="pmc">PMC10935157</ArticleId><ArticleId IdType="pubmed">38474807</ArticleId></ArticleIdList></Reference><Reference><Citation>Sîrbu AC, Sabin O, Bocșan IC, Vesa ȘC, Buzoianu AD. The effect of vitamin D supplementation on the length of hospitalisation, intensive care unit admission, and mortality in COVID-19-a systematic review and Meta-analysis. Nutrients. (2023) 15:3470. doi: 10.3390/nu15153470, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15153470</ArticleId><ArticleId IdType="pmc">PMC10421164</ArticleId><ArticleId IdType="pubmed">37571407</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ecclesiis O, Gavioli C, Martinoli C, Raimondi S, Chiocca S, Miccolo C, et al. . Vitamin D and SARS-CoV2 infection, severity and mortality: a systematic review and meta-analysis. PLoS One. (2022) 17:e0268396. doi: 10.1371/journal.pone.0268396, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0268396</ArticleId><ArticleId IdType="pmc">PMC9258852</ArticleId><ArticleId IdType="pubmed">35793346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini B, El Abd A, Ducharme FM. Effects of vitamin D supplementation on COVID-19 related outcomes: a systematic review and meta-analysis. Nutrients. (2022) 14:2134. doi: 10.3390/nu14102134, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102134</ArticleId><ArticleId IdType="pmc">PMC9147949</ArticleId><ArticleId IdType="pubmed">35631275</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. . Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. (2017) 356:i6583. doi: 10.1136/bmj.i6583</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i6583</ArticleId><ArticleId IdType="pmc">PMC5310969</ArticleId><ArticleId IdType="pubmed">28202713</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin G, Hewison M, Hopkin J, Kenny RA, Quinton R, Rhodes J, et al. . Perspective: vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19. Clin Med (Lond). (2021) 21:e144–9. doi: 10.7861/clinmed.2021-0035, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0035</ArticleId><ArticleId IdType="pmc">PMC8002781</ArticleId><ArticleId IdType="pubmed">33593830</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiner Solís Á, Avedillo Salas A, Luesma Bartolomé MJ, Santander Ballestín S. The effects of vitamin D supplementation in COVID-19 patients: a systematic review. Int J Mol Sci. (2022) 23:12424. doi: 10.3390/ijms232012424, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232012424</ArticleId><ArticleId IdType="pmc">PMC9604062</ArticleId><ArticleId IdType="pubmed">36293279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketha H, Thacher TD, Oberhelman SS, Fischer PR, Singh RJ, Kumar R. Comparison of the effect of daily versus bolus dose maternal vitamin D(3) supplementation on the 24,25-dihydroxyVitamin D(3) to 25-hydroxyVitamin D(3) ratio. Bone. (2018) 110:321–5. doi: 10.1016/j.bone.2018.02.024, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2018.02.024</ArticleId><ArticleId IdType="pmc">PMC5878742</ArticleId><ArticleId IdType="pubmed">29486367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu R, Chain BM, Coussens AK, Khoo B, Noursadeghi M. Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. Eur J Immunol. (2014) 44:1781–90. doi: 10.1002/eji.201344157, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201344157</ArticleId><ArticleId IdType="pubmed">24643654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall-Gremstrup G, Holt R, Yahyavi SK, Jorsal MJ, Juul A, Jørgensen N, et al. . High-dose vitamin D(3) supplementation shows no beneficial effects on white blood cell counts, acute phase reactants, or frequency of respiratory infections. Respir Res. (2024) 25:11. doi: 10.1186/s12931-023-02642-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02642-9</ArticleId><ArticleId IdType="pmc">PMC10765571</ArticleId><ArticleId IdType="pubmed">38178229</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res. (2009) 29:3675–84. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">19667164</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, et al. . Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyVitamin D in human monocytes. J Bone Miner Res. (2013) 28:46–55. doi: 10.1002/jbmr.1740, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.1740</ArticleId><ArticleId IdType="pmc">PMC3511915</ArticleId><ArticleId IdType="pubmed">22886720</ArticleId></ArticleIdList></Reference><Reference><Citation>Coudray MS, Hansel S, Alesci S, Meyer WA, 3rd, Christenson RH, Landry LG, et al. . Vitamin D levels and SARS-CoV-2 infection among medically underserved populations in the minority and rural coronavirus insights study. Viruses. (2024) 16:639. doi: 10.3390/v16040639, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16040639</ArticleId><ArticleId IdType="pmc">PMC11053904</ArticleId><ArticleId IdType="pubmed">38675979</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng J, Li X, Liu W, Xiao Y, Tang H, Wu Y, et al. . The role of vitamin D in the prevention and treatment of SARS-CoV-2 infection: a meta-analysis of randomized controlled trials. Clin Nutr. (2023) 42:2198–206. doi: 10.1016/j.clnu.2023.09.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2023.09.008</ArticleId><ArticleId IdType="pubmed">37802017</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant WB, Al Anouti F, Boucher BJ, Dursun E, Gezen-Ak D, Jude EB, et al. . A narrative review of the evidence for variations in serum 25-HydroxyVitamin D concentration thresholds for optimal health. Nutrients. (2022) 14:639. doi: 10.3390/nu14030639, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14030639</ArticleId><ArticleId IdType="pmc">PMC8838864</ArticleId><ArticleId IdType="pubmed">35276999</ArticleId></ArticleIdList></Reference><Reference><Citation>Cawood AL, Walters ER, Smith TR, Sipaul RH, Stratton RJ. A review of nutrition support guidelines for individuals with or recovering from COVID-19 in the community. Nutrients. (2020) 12:3230. doi: 10.3390/nu12113230, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12113230</ArticleId><ArticleId IdType="pmc">PMC7690369</ArticleId><ArticleId IdType="pubmed">33105731</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin G, Hewison M, Hopkin J, Kenny RA, Quinton R, Rhodes J, et al. . Preventing vitamin D deficiency during the COVID-19 pandemic: UK definitions of vitamin D sufficiency and recommended supplement dose are set too low. Clin Med (Lond). (2021) 21:e48–51. doi: 10.7861/clinmed.2020-0858, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0858</ArticleId><ArticleId IdType="pmc">PMC7850219</ArticleId><ArticleId IdType="pubmed">33158957</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>